arrow_right
OUR PRODUCTS
Veracyte's genomic tests are setting new standards in thyroid cancer, lung cancer and interstitial lung disease, where they are helping to inform both diagnosis and treatment decisions. Our first-of-their-kind genomic classifiers are uniquely developed using RNA whole-transcriptome sequencing and machine learning to answer specific clinical questions that improve patient care.

Learn more at Veracyte.com or via the product pages linked below.
  • Envisia
    Increasing confidence in interstitial lung disease diagnosis
    Learn more  >
  • Afirma
    Reducing unnecessary surgeries and informing treatment decisions in thyroid cancer diagnosis
    Learn more  >
  • Percepta
    Reducing unnecessary invasive procedures and guiding next steps in lung cancer evaluation
    Learn more  >
CONTACT A REP TO ORDER VERACYTE TESTING
Veracyte representatives are happy to assist you and to discuss how to integrate our tests into your practice.
First Name
Last Name
Email
Institution
Zip Code
Which Test Interests You?
More About You
Message
CONTACT REP
© 2020 Veracyte, Inc. All rights reserved.